These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1535413)

  • 21. Low blood pressure in Down's syndrome, A link with Alzheimer's disease?
    Morrison RA; McGrath A; Davidson G; Brown JJ; Murray GD; Lever AF
    Hypertension; 1996 Oct; 28(4):569-75. PubMed ID: 8843880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Drachman DA; Smith TW; Alkamachi B; Kane K
    Alzheimers Dement; 2017 Dec; 13(12):1389-1396. PubMed ID: 28627379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    Castro P; Zaman S; Holland A
    J Neurol; 2017 Apr; 264(4):804-813. PubMed ID: 27778163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.
    Elovaara I; Maury CP; Palo J
    Acta Neurol Scand; 1986 Sep; 74(3):245-50. PubMed ID: 2947417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration.
    Sawa A
    J Neural Transm Suppl; 2001; (61):361-71. PubMed ID: 11771759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and down syndrome: from meiosis to dementia.
    Petronis A
    Exp Neurol; 1999 Aug; 158(2):403-13. PubMed ID: 10415146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.
    Hayn M; Kremser K; Singewald N; Cairns N; Nemethova M; Lubec B; Lubec G
    Life Sci; 1996; 59(7):537-44. PubMed ID: 8761342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.
    Fonseca MI; Head E; Velazquez P; Cotman CW; Tenner AJ
    Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laminar distribution of neuritic plaques in normal aging, Alzheimer's disease and Down's syndrome.
    Rafalowska J; Barcikowska M; Wen GY; Wisniewski HM
    Acta Neuropathol; 1988; 77(1):21-5. PubMed ID: 2977047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ApoE2 allele, Down's syndrome, and dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts GW
    Ann N Y Acad Sci; 1996 Jan; 777():255-9. PubMed ID: 8624094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.
    Ferrer I; Gullotta F
    Acta Neuropathol; 1990; 79(6):680-5. PubMed ID: 2141748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain evolution and Alzheimer's disease.
    Rapoport SI
    Rev Neurol (Paris); 1988; 144(2):79-90. PubMed ID: 2898165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
    Su JH; Kesslak JP; Head E; Cotman CW
    Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome.
    Deutsch SI; Burket JA; Benson AD
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():131-9. PubMed ID: 24865150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.